SCHEMBL19936650

SCHEMBL19936650

CCn1nc(-c2ccc(C)cc2OC)cc1NC=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
CREBBP Q92793 1/20 0.36
CRHR1 P34998 2/20 0.35
TP53 P04637 1/20 0.35
POLB P06746 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
BRD9 Q9H8M2 1/20 0.34
TSHR P16473 2/20 0.33
ACHE P22303 1/20 0.33
USP2 O75604 1/20 0.33
HTT P42858 1/20 0.33
HSD17B10 Q99714 1/20 0.33
RECQL P46063 1/20 0.33
CHEK1 O14757 1/20 0.32
NEK2 P51955 1/20 0.32
LIMK1 P53667 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19936673 0.87 HSP90AA1 (0.40) ALDH1A1CRHR1TP53POLBTSHR
SCHEMBL19936502 0.87 KCNH2 (0.41)
SCHEMBL19936582 0.84 ALDH1A1 (0.38) KMT2AMEN1ALDH1A1KDM4EMAPT
SCHEMBL3435083 0.76 KMT2A (0.47) KMT2AMEN1ALDH1A1KDM4EMAPT
SCHEMBL19936484 0.75 ALDH1A1 (0.37) KMT2AMEN1ALDH1A1KDM4EMAPT
SCHEMBL10049090 0.75 ALDH1A1 (0.37) KMT2AMEN1ALDH1A1KDM4EMAPT
SCHEMBL19936669 0.70 ACHE (0.40) KMT2AMEN1ALDH1A1KDM4EMAPT
SCHEMBL10330271 0.70 GAA (0.53) ALDH1A1KDM4EMAPTTSHRSMN1; SMN2
SCHEMBL19936498 0.69 ALDH1A1 (0.44) ALDH1A1KDM4EMAPTTP53POLB
SCHEMBL10049017 0.66 CA1 (0.41) CREBBPCRHR1POLBTDP1BRD9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2594555-B1 HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR ASKA PHARM CO LTD (JP) 2018-03-07 EP disclosed